Adrenal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

A. Berruti; E. Baudin; H. Gelderblom; H. R. Haak; F. Porpiglia; M. Fassnacht; G. Pentheroudakis

doi:10.1093/annonc/mds231

Adrenal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

A. Berruti, E. Baudin, H. Gelderblom, H. R. Haak, F. Porpiglia, M. Fassnacht, G. Pentheroudakis

Résultats de recherche: Contribution à un journal › Article › Revue par des pairs

267 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	vii131-vii138
journal	Annals of Oncology
Volume	23
Numéro de publication	SUPPL. 7
Les DOIs	https://doi.org/10.1093/annonc/mds231
état	Publié - 1 janv. 2012

Accès au document

10.1093/annonc/mds231

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

@article{2ef6ecfb61634d3399f6d7694ca3d257,

title = "Adrenal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up",

author = "A. Berruti and E. Baudin and H. Gelderblom and Haak, {H. R.} and F. Porpiglia and M. Fassnacht and G. Pentheroudakis",

note = "Funding Information: Dr. Berruti has reported: advisory board honorarium from Astellas. Prof. Fassnacht has reported Principal Investigator of a study funded by HRA Pharma, Research grants: Pfizer, Astellas Pharma. The other authors have reported no potential conflicts of interest.",

year = "2012",

month = jan,

day = "1",

doi = "10.1093/annonc/mds231",

language = "English",

volume = "23",

pages = "vii131--vii138",

journal = "Annals of Oncology",

issn = "0923-7534",

number = "SUPPL. 7",

}

TY - JOUR

T1 - Adrenal cancer

T2 - ESMO clinical practice guidelines for diagnosis, treatment and follow-up

AU - Berruti, A.

AU - Baudin, E.

AU - Gelderblom, H.

AU - Haak, H. R.

AU - Porpiglia, F.

AU - Fassnacht, M.

AU - Pentheroudakis, G.

N1 - Funding Information: Dr. Berruti has reported: advisory board honorarium from Astellas. Prof. Fassnacht has reported Principal Investigator of a study funded by HRA Pharma, Research grants: Pfizer, Astellas Pharma. The other authors have reported no potential conflicts of interest.

PY - 2012/1/1

Y1 - 2012/1/1

UR - http://www.scopus.com/inward/record.url?scp=84866628998&partnerID=8YFLogxK

U2 - 10.1093/annonc/mds231

DO - 10.1093/annonc/mds231

M3 - Article

C2 - 22997446

AN - SCOPUS:84866628998

SN - 0923-7534

VL - 23

SP - vii131-vii138

JO - Annals of Oncology

JF - Annals of Oncology

IS - SUPPL. 7

ER -